Ameritas Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $76.5K | Buy |
+609
| New | +$76.5K | ﹤0.01% | 1100 |
|
2024
Q4 | – | Sell |
-2,187
| Closed | -$424K | – | 878 |
|
2024
Q3 | $424K | Buy |
2,187
+880
| +67% | +$171K | 0.02% | 585 |
|
2024
Q2 | $303K | Sell |
1,307
-15
| -1% | -$3.48K | 0.01% | 726 |
|
2024
Q1 | $284K | Sell |
1,322
-164
| -11% | -$35.2K | 0.01% | 726 |
|
2023
Q4 | $377K | Sell |
1,486
-17
| -1% | -$4.32K | 0.02% | 494 |
|
2023
Q3 | $390K | Buy |
+1,503
| New | +$390K | 0.02% | 564 |
|
2023
Q2 | – | Sell |
-1,577
| Closed | -$454K | – | 745 |
|
2023
Q1 | $454K | Sell |
1,577
-9
| -0.6% | -$2.59K | 0.02% | 513 |
|
2022
Q4 | $439K | Sell |
1,586
-12
| -0.8% | -$3.32K | 0.02% | 579 |
|
2022
Q3 | $427K | Sell |
1,598
-38
| -2% | -$10.2K | 0.03% | 474 |
|
2022
Q2 | $334K | Sell |
1,636
-37
| -2% | -$7.55K | 0.02% | 576 |
|
2022
Q1 | $352K | Sell |
1,673
-118
| -7% | -$24.8K | 0.01% | 607 |
|
2021
Q4 | $430K | Buy |
+1,791
| New | +$430K | 0.02% | 537 |
|